| 2023-08-23 | NRx Pharmaceuticals, Inc. NRXP | Chief Scientist | 100,000 0.135% | $0.33 | $33,000 | +20.42% | ||
| 2023-08-22 | NRx Pharmaceuticals, Inc. NRXP | Chief Scientist | 200,000 0.2614% | $0.32 | $64,400 | +12.58% | ||
| 2022-12-07 | Sale | NRx Pharmaceuticals, Inc. NRXP | director | 400,000 0.4224% | $1.00 | $400,000 | -63.19% | |
| 2022-06-01 | NRx Pharmaceuticals, Inc. NRXP | Chief Scientist | 100,000 0.1543% | $0.58 | $58,000 | +29.02% | ||
| 2009-10-22 | Sale | Brainstorm Cell Therapeutics Inc. BCLI | director | 31,610 0.0447% | $0.32 | $10,115 | -29.73% | |
| 2009-10-14 | Sale | Brainstorm Cell Therapeutics Inc. BCLI | director | 60,000 0.1047% | $0.32 | $19,200 | -13.33% | |
| 2009-10-06 | Sale | Brainstorm Cell Therapeutics Inc. BCLI | director | 48,869 0.0811% | $0.34 | $16,371 | -21.21% | |
| 2009-10-05 | Sale | Brainstorm Cell Therapeutics Inc. BCLI | director | 87,509 0.1453% | $0.34 | $29,324 | -21.21% | |
| 2009-10-02 | Sale | Brainstorm Cell Therapeutics Inc. BCLI | director | 5,224 0.0089% | $0.34 | $1,750 | -18.75% | |
| 2009-10-01 | Sale | Brainstorm Cell Therapeutics Inc. BCLI | director | 2,800 0.0046% | $0.34 | $952 | -23.53% | |
| 2009-09-30 | Sale | Brainstorm Cell Therapeutics Inc. BCLI | director | 50,000 0.0859% | $0.32 | $15,760 | -13.33% | |
| 2009-09-29 | Sale | Brainstorm Cell Therapeutics Inc. BCLI | director | 213,988 0.3506% | $0.34 | $71,986 | -22.06% | |
| 2008-08-27 | Sale | Brainstorm Cell Therapeutics Inc. BCLI | director | 80,000 0.1442% | $0.25 | $20,000 | -70.37% |